This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Arjil Biotech Holding Company Limited. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Innovations by Wei-Chung Chiou in the Fight Against Coronavirus
Introduction
Wei-Chung Chiou is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of medical science, particularly in the development of compounds aimed at combating viral infections. His work is especially relevant in the context of the ongoing global health challenges posed by coronaviruses.
Latest Patents
Wei-Chung Chiou holds a patent for "Compounds and methods for prevention and treatment of coronavirus infections." This invention pertains to anti-coronaviral compounds and includes a method for preventing and/or treating a coronavirus infection through the inhibition of a cysteine protease in a virus, particularly SARS-COV-2. The patent also covers the composition and pharmaceutical composition for preventing and/or treating a coronavirus infection, comprising any of the compounds, pharmaceutically acceptable salts thereof, or their mixtures.
Career Highlights
Chiou is associated with Arjil Biotech Holding Company Limited, where he applies his expertise in biotechnology to develop innovative solutions for health-related issues. His work has garnered attention for its potential impact on public health, especially during times of viral outbreaks.
Collaborations
Some of his notable coworkers include Jir-Mehng Lo and Cheng Huang, who contribute to the collaborative efforts in research and development within the company.
Conclusion
Wei-Chung Chiou's innovative work in developing anti-coronaviral compounds highlights the importance of scientific research in addressing global health challenges. His contributions are vital in the ongoing fight against coronavirus infections, showcasing the role of inventors in advancing medical science.